Quantinuum’s (QNT) “Buy” Rating Reiterated at Rosenblatt Securities

Quantinuum (NASDAQ:QNT)‘s stock had its “buy” rating reaffirmed by equities research analysts at Rosenblatt Securities in a research note issued on Wednesday,Benzinga reports. They presently have a $155.00 price target on the stock. Rosenblatt Securities’ price target would suggest a potential upside of 176.49% from the stock’s current price.

QNT has been the subject of a number of other research reports. Mizuho assumed coverage on Quantinuum in a report on Monday, June 29th. They issued an “outperform” rating and a $90.00 price objective for the company. Sanford C. Bernstein started coverage on Quantinuum in a research report on Monday, June 29th. They set an “outperform” rating and a $94.00 target price for the company. Wall Street Zen cut Quantinuum from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. Evercore started coverage on shares of Quantinuum in a research report on Monday, June 29th. They issued an “outperform” rating and a $98.00 price target on the stock. Finally, Zacks Research upgraded shares of Quantinuum to a “hold” rating in a report on Tuesday, June 30th. Twelve analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Quantinuum has an average rating of “Moderate Buy” and a consensus price target of $98.33.

Quantinuum Trading Down 0.9%

Shares of QNT stock opened at $56.06 on Wednesday. The firm has a 50 day simple moving average of $62.71. Quantinuum has a 52-week low of $47.06 and a 52-week high of $86.79.

Quantinuum (NASDAQ:QNT) last posted its quarterly earnings results on Tuesday, August 11th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The firm had revenue of $8.00 million during the quarter. As a group, equities analysts anticipate that Quantinuum will post -1.61 earnings per share for the current year.

Insider Activity at Quantinuum

In other Quantinuum news, insider Kevin Scott Dehoff bought 15,000 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was acquired at an average cost of $60.00 per share, with a total value of $900,000.00. Following the purchase, the insider owned 126,460 shares in the company, valued at $7,587,600. This trade represents a 13.46% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Michal Stepniak purchased 13,333 shares of the business’s stock in a transaction on Friday, June 5th. The stock was bought at an average cost of $60.00 per share, for a total transaction of $799,980.00. Following the purchase, the director owned 13,333 shares of the company’s stock, valued at approximately $799,980. This represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 411,032 shares of company stock valued at $24,661,920 over the last 90 days.

Institutional Investors Weigh In On Quantinuum

An institutional investor recently bought a new stake in Quantinuum stock. Lisanti Capital Growth LLC acquired a new stake in Quantinuum Inc. (NASDAQ:QNT) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 5,005 shares of the company’s stock, valued at approximately $409,000.

More Quantinuum News

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum reported second-quarter revenue of $8 million, a 279% year-over-year increase, and raised its fiscal 2026 revenue outlook to $28 million-$32 million versus the $26.6 million analyst consensus. Quantinuum Reports Second Quarter 2026 Results
• Positive Sentiment: Quantinuum announced a multiyear partnership with Oracle (NYSE: ORCL) to deploy its 98-qubit Helios system in a U.S.-based Oracle Cloud Infrastructure AI data center. Customers will be able to access hybrid quantum-AI and high-performance computing capabilities through Oracle Cloud without owning specialized quantum hardware, potentially accelerating commercial adoption. Oracle, Quantinuum partner to bring quantum computing to cloud
• Positive Sentiment: The company said Helios demonstrated near five-nines logical fidelity, reinforcing Quantinuum’s positioning in fault-tolerant quantum computing. The Oracle deployment could provide an important bridge from technical milestones to applications such as drug discovery, materials science, financial modeling and optimization. Quantinuum Puts a 98-Qubit Helios Machine Inside Oracle’s AI Data Centers
• Negative Sentiment: Quantinuum reported an adjusted loss of $0.28 per share, slightly worse than the $0.26 consensus estimate. The earnings shortfall and the company’s still-small revenue base appear to have outweighed the favorable outlook and strategic partnership, helping explain why the stock finished lower. Quantinuum Reports Second Quarter 2026 Results

About Quantinuum

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.